Virginia Retirement Systems’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$717K Buy
76,000
+1,500
+2% +$12K ﹤0.01% 816
2026
Q2
$652K Buy
+74,500
New +$564K ﹤0.01% 886
2023
Q1
– Sell
-11,000
Closed -$55.8K – 1136
2022
Q4
$55.8K Sell
11,000
-3,100
-22% -$17K ﹤0.01% 1111
2022
Q3
$70.1K Buy
+14,100
New +$64.3K ﹤0.01% 1130
2022
Q1
$122K Buy
21,800
+8,300
+61% +$50.9K ﹤0.01% 1083
2021
Q4
$82K Buy
+13,500
New +$101K ﹤0.01% 1091

Other funds holding IBRX

Virginia Retirement Systems's IBRX Position: Q3 2026 in Review

Virginia Retirement Systems increased its ImmunityBio (IBRX) stake by 2% in Q3 2026, buying an estimated $12K and bringing the position to 76,000 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Virginia Retirement Systems first reported a position in IBRX in Q4 2021 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Virginia Retirement Systems held 76,000 shares of ImmunityBio worth $717K as of Q3 2026.
  • Virginia Retirement Systems bought 1,500 ImmunityBio shares in Q3 2026, an estimated $12K.
  • ImmunityBio made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #816 holding.
  • Virginia Retirement Systems first reported a position in ImmunityBio in Q4 2021 and has held it in 6 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.